Medivis Secures Fda Clearance For Breakthrough Augmented Reality
Medivis Secures Fda Clearance For Breakthrough Augmented Reality New york, may 30, 2019 prnewswire medivis announced today that its groundbreaking augmented reality (ar) technology platform for surgical applications, surgicalar, has received 510 (k. Medivis announced today that its groundbreaking augmented reality (ar) technology platform for surgical applications, surgicalar, has received 510 (k) clearance for clinical use in the operating room by the u.s. food and drug administration. the new york city based medical technology company will commence the immediate commercialization of the.
Medivis Wins Fda Clearance For Breakthrough Augmented Reality Surgical Medivis announced today that its groundbreaking augmented reality (ar) technology platform for surgical applications, surgicalar, has received 510(k) clearance for clinical use in the operating room by the u.s. food and drug administration. Spine navigation, pending fda 510 (k) clearance, for pedicle screw placement is compatible across a range of surgical equipment. cranial, body and spine navigation products are under development and not commercially available at this time. “augmented reality is a disruptive technology that has just begun to change how we practice neurosurgery. New york, ny —— medivis, a medical technology company with the mission to establish augmented reality as the new standard in surgical navigation, announced a $20 million series a funding round led by thrive capital, with participation from initialized capital and mayo clinic. additional investors include bob iger, kevin durant, dr. robert. New york, ny, june 13, 2023— (prnewswire)— medivis, a medical technology company with the mission to establish augmented reality as the new standard in surgical navigation, announced a $20 million series a funding round led by thrive capital, with participation from initialized capital and mayo clinic. additional investors include bob iger.
Medivis Wins Fda Clearance For Breakthrough Augmented Reality Surgical New york, ny —— medivis, a medical technology company with the mission to establish augmented reality as the new standard in surgical navigation, announced a $20 million series a funding round led by thrive capital, with participation from initialized capital and mayo clinic. additional investors include bob iger, kevin durant, dr. robert. New york, ny, june 13, 2023— (prnewswire)— medivis, a medical technology company with the mission to establish augmented reality as the new standard in surgical navigation, announced a $20 million series a funding round led by thrive capital, with participation from initialized capital and mayo clinic. additional investors include bob iger. This groundbreaking augmented reality surgical planning toolkit, surgicalar has won clearance for clinical use in the operating room by the food and drug administration. launched surgicalar earlier this year, the company will commence the immediate commercialization of the platform in the u.s. The fundraise will be used to scale engineering, obtain regulatory clearances and globally commercialize across multiple specialties including neurosurgery, orthopedic surgery, interventional radiology and reconstructive surgery.
Medivis Wins Fda Clearance For Breakthrough Augmented Reality Surgical This groundbreaking augmented reality surgical planning toolkit, surgicalar has won clearance for clinical use in the operating room by the food and drug administration. launched surgicalar earlier this year, the company will commence the immediate commercialization of the platform in the u.s. The fundraise will be used to scale engineering, obtain regulatory clearances and globally commercialize across multiple specialties including neurosurgery, orthopedic surgery, interventional radiology and reconstructive surgery.
Medivis Wins Fda Clearance For Breakthrough Augmented Reality Surgical
Comments are closed.